David Kandzari reviews the Spyral-HTN On study results for control of hypertension using renal denervation

1,190 views | 26 Oct 2018

364 videos

SPYRAL HTN-ON MED confirmed RDN’s blood pressure lowering effect, in patients prescribed BP medications, at 6-months1

  • 24-hour systolic ambulatory blood pressure (ABPM) decreased 9.0 mmHg in...
Read More
User Dr. David Kandzari uploaded avatar

Dr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service Line; Director,...

Read More
Start a conversation